Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors Based on a systematic review, an international ...
Any guideline-promulgating body must use a universal methodology to facilitate the job of holding guidelines to a rigorous standard. Health care providers often treat the same illnesses differently.
Utilization management criteria influence patients’ access to specialty drugs, yet the processes used by health plans to establish these criteria are not well understood. This study examined the ...
The National Comprehensive Cancer Network (NCCN)-the nonprofit alliance of leading cancer centers responsible for essential NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) that ...
6d
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
The National Comprehensive Cancer Network® (NCCN®)—the nonprofit alliance of leading cancer centers responsible for essential NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) that ...
Various problems with guidelines and their development that can impede their maximal use and profit have been reported: The final AGREE instrument consists of 23 key ...
Monash University calls for public input on first dementia guidelines update in a decade; Monash University calls for public input on first de ...
Aim The Royal Dutch Society for Physical Therapy (KNGF) instructed a multidisciplinary group of Dutch anterior cruciate ligament (ACL) experts to develop an evidence statement for rehabilitation after ...
Correspondence to Dr Roula Kotsifaki, Rehabilitation Department, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar; argyro.kotsifaki{at}aspetar.com This guideline was developed to inform ...
More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new ...
Research has documented numerous conflicts of interest (COI) in which pharmaceutical industry money is paid to researchers, APA board members, New studies reveal that conflicted FDA speakers are up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results